Issue link: https://viewer.e-digitaledition.com/i/1102201
Groundbreaking Research at UPMC Pinnacle UPMC PINNACLE CONTINUES THE TR ADITION OF ELE VATING CARDIOVA SCUL AR CARE IN CENTR AL PENNSYLVANIA — AND BE YOND — IN NE W, INNOVATIVE WAYS. SINCE 1997, PINNACLEHE ALTH CARDIOVA SCUL AR INSTITUTE'S (PHCVI) CLINICAL TRIALS HAVE TR ANSFORMED CARDIOVA SCUL AR MEDICINE, INTRODUCING NE W THER APIES — SUCH A S TR ANSCATHE TER AORTIC VALVE REPL ACEMENT (TAVR), INTERCOSTAL SURGICAL VALVE REPL ACEMENT (iSVR) AND THE L ATEST IN TR ANSCATHE TER MITR AL VALVE REPL ACEMENT — TO OUR COMMUNIT Y BEFORE THE Y WERE AVAIL ABLE ELSE WHERE. BEGINNING IN 2011, PHCVI participated in the pivotal national clinical trial for minimally invasive TAVR procedures among high- risk patients. Our team of cardiovascular specialists continues to hone our expertise and pursue safety advancements with TAVR. Through clinical trials, we have helped develop sleeker devices, enhancing clinical outcomes and reducing complications. During valve replacement, we aim to reduce the stroke rate to as close to zero as possible. In every case in which our patient is anatomically suited, we utilize embolic protection devices to capture and remove harmful debris during TAVR procedures. Left unaddressed, the debris could cause blockages, potentially leading to stroke. During the evolution of TAVR, our surgical team developed iSVR, a new method for valve replacement surgery. During the iSVR procedure — also a minimally invasive approach for repairing dam- aged valves — a small incision is made without cutting breastbone. This allows us to enter through the rib space and preserve muscle and cartilage, which results in fewer complications and less pain. iSVR yields excellent results for patients needing aortic, mitral or double valve replacement, as well as some coronary artery bypass grafts. It offers less scarring, quicker recovery, decreased time in the ICU and a lower chance of a blood transfusion. According to a r ticles in T he Annals of T horacic Surgery a nd Health Services Research, higher volumes a re correlated with better patient outcomes. UPMC Pinnacle continues to pursue higher levels of expertise and perform more procedures than other hospita ls, enabling us to offer our cardiac patients heightened sa fet y measures a nd improved outcomes. Our experience has a lso a llowed us to apply brea kthrough therapies to populations who previously may not have been recog nized as good ca ndidates for treatment. For exa mple, at U PMC P i n n a cle, it i s not u ncom mon for people who a re 90 or 100 yea rs old to undergo a TAV R procedure. Each week, our multidisciplina r y specia lists meet to a ssess our patients and collectively determine the treatment best suited to each patient. O u r h i s t or y of exc el lenc e i n c a rd iov a sc u l a r cl i n ic a l t r ia l s m a kes cent ra l Pennsylva nia at trac- tive to ca rdiovascula r device companies test- ing the latest therapies. We c ont i nue t o pl ay a n a c t i v e r ol e a t a n internationa l level in cli n ica l tr ia ls — now by t e s t i n g t he l at e s t a d v a n c e s i n t r a n s - catheter mitra l va lve tech nolog ies. It is a n e x c i t i n g t i m e t o b e i n v o l v e d i n c a r d i o - va scu la r medicine at UPMC Pinnacle. ■ iSVR incision BY HEMAL GADA, MD, MBA, MEDICAL DIRECTOR OF STRUCTURAL HEART AT UPMC PINNACLE Moves Cardiovascular Care Forward Embolic protection device M D N E W S . C O M /// M D N E W S M I D - P E N N ■ 2 019 0 7 L E A D I N G - E D G E T R E A T M E N T ❰❰❰❰❰ 0 7

